BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benilova I, Reilly M, Terry C, Wenborn A, Schmidt C, Marinho AT, Risse E, Al-Doujaily H, Wiggins De Oliveira M, Sandberg MK, Wadsworth JDF, Jat PS, Collinge J. Highly infectious prions are not directly neurotoxic. Proc Natl Acad Sci U S A 2020;117:23815-22. [PMID: 32900920 DOI: 10.1073/pnas.2007406117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Jack K, Jackson GS, Bieschke J. Essential Components of Synthetic Infectious Prion Formation De Novo. Biomolecules 2022;12:1694. [DOI: 10.3390/biom12111694] [Reference Citation Analysis]
2 Manka SW, Wenborn A, Collinge J, Wadsworth JDF. Prion strains viewed through the lens of cryo-EM. Cell Tissue Res 2022. [PMID: 36028585 DOI: 10.1007/s00441-022-03676-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sangar D, Jack K, Batchelor M, Mistry B, Bieschke J. Syntaxin 6 delays prion protein fibril formation and prolongs presence of toxic aggregation intermediates.. [DOI: 10.1101/2022.08.25.505283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nikolić L, Ferracin C, Legname G. Recent advances in cellular models for discovering prion disease therapeutics. Expert Opin Drug Discov 2022. [PMID: 35983689 DOI: 10.1080/17460441.2022.2113773] [Reference Citation Analysis]
5 Naeimi WR, Serio TR. Beyond Amyloid Fibers: Accumulation, Biological Relevance, and Regulation of Higher-Order Prion Architectures. Viruses 2022;14:1635. [PMID: 35893700 DOI: 10.3390/v14081635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bradford BM, Mcguire LI, Hume DA, Pridans C, Mabbott NA. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain. Glia. [DOI: 10.1002/glia.24244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Dexter E, Kong Q. Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review. Expert Rev Neurother 2021;21:969-82. [PMID: 34470561 DOI: 10.1080/14737175.2021.1965881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Makarava N, Mychko O, Chang JC, Molesworth K, Baskakov IV. The degree of astrocyte activation is predictive of the incubation time to prion disease. Acta Neuropathol Commun 2021;9:87. [PMID: 33980286 DOI: 10.1186/s40478-021-01192-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
9 Zanier ER, Barzago MM, Vegliante G, Romeo M, Restelli E, Bertani I, Natale C, Colnaghi L, Colombo L, Russo L, Micotti E, Fioriti L, Chiesa R, Diomede L. C. elegans detects toxicity of traumatic brain injury generated tau. Neurobiol Dis 2021;153:105330. [PMID: 33711491 DOI: 10.1016/j.nbd.2021.105330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kushwaha R, Sinha A, Makarava N, Molesworth K, Baskakov IV. Non-cell autonomous astrocyte-mediated neuronal toxicity in prion diseases. Acta Neuropathol Commun 2021;9:22. [PMID: 33546775 DOI: 10.1186/s40478-021-01123-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
11 Kawahara M, Kato-Negishi M, Tanaka KI. Neurometals in the Pathogenesis of Prion Diseases. Int J Mol Sci 2021;22:1267. [PMID: 33525334 DOI: 10.3390/ijms22031267] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Bradford BM, Mcguire LI, Hume DA, Pridans C, Mabbott NA. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.. [DOI: 10.1101/2021.01.05.425436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Forloni G, La Vitola P, Cerovic M, Balducci C. Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight. Prog Mol Biol Transl Sci 2021;177:175-202. [PMID: 33453941 DOI: 10.1016/bs.pmbts.2020.11.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]